trending Market Intelligence /marketintelligence/en/news-insights/trending/XeKOSdgmaS8HRj2E-fibSw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Antares submits new drug application to FDA for Quickshot Testosterone

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Antares submits new drug application to FDA for Quickshot Testosterone

Antares Pharma Inc. submitted a new drug application to the U.S. FDA for its QuickShot Testosterone, a drug-device combination product for treating men with low testosterone associated with hypogonadism.

The product delivers testosterone enanthate using a subcutaneous auto injector.